Categories
- Global News Feed
- Uncategorized
- Alabama Stem Cells
- Alaska Stem Cells
- Arkansas Stem Cells
- Arizona Stem Cells
- California Stem Cells
- Colorado Stem Cells
- Connecticut Stem Cells
- Delaware Stem Cells
- Florida Stem Cells
- Georgia Stem Cells
- Hawaii Stem Cells
- Idaho Stem Cells
- Illinois Stem Cells
- Indiana Stem Cells
- Iowa Stem Cells
- Kansas Stem Cells
- Kentucky Stem Cells
- Louisiana Stem Cells
- Maine Stem Cells
- Maryland Stem Cells
- Massachusetts Stem Cells
- Michigan Stem Cells
- Minnesota Stem Cells
- Mississippi Stem Cells
- Missouri Stem Cells
- Montana Stem Cells
- Nebraska Stem Cells
- New Hampshire Stem Cells
- New Jersey Stem Cells
- New Mexico Stem Cells
- New York Stem Cells
- Nevada Stem Cells
- North Carolina Stem Cells
- North Dakota Stem Cells
- Oklahoma Stem Cells
- Ohio Stem Cells
- Oregon Stem Cells
- Pennsylvania Stem Cells
- Rhode Island Stem Cells
- South Carolina Stem Cells
- South Dakota Stem Cells
- Tennessee Stem Cells
- Texas Stem Cells
- Utah Stem Cells
- Vermont Stem Cells
- Virginia Stem Cells
- Washington Stem Cells
- West Virginia Stem Cells
- Wisconsin Stem Cells
- Wyoming Stem Cells
- Biotechnology
- Cell Medicine
- Cell Therapy
- Diabetes
- Epigenetics
- Gene therapy
- Genetics
- Genetic Engineering
- Genetic medicine
- HCG Diet
- Hormone Replacement Therapy
- Human Genetics
- Integrative Medicine
- Molecular Genetics
- Molecular Medicine
- Nano medicine
- Preventative Medicine
- Regenerative Medicine
- Stem Cells
- Stell Cell Genetics
- Stem Cell Research
- Stem Cell Treatments
- Stem Cell Therapy
- Stem Cell Videos
- Testosterone Replacement Therapy
- Testosterone Shots
- Transhumanism
- Transhumanist
Archives
Recommended Sites
Category Archives: Cell Therapy
Cedars-Sinai Heart Institute Opens First-of-its-Kind Research Stem Cell Clinic for Cardiac Patients
Posted: August 13, 2014 at 7:42 am
Contact Information
Available for logged-in reporters only
Newswise LOS ANGELES (Aug. 12, 2014) Regenerative medicine experts at the Cedars-Sinai Heart Institute have opened a new clinic to evaluate heart and vascular disease patients for participation in stem cell medical studies.
Led by Eduardo Marbn, MD, PhD, director of the Cedars-Sinai Heart Institute, and Timothy Henry, MD, director of the Heart Institutes Cardiology Division, the doctors and researchers at the Cedars-Sinai Heart Institute Regenerative Medicine Clinic use a scientific approach to assess the possible benefits of stem cells to repair damaged or diseased cardiovascular tissues. The clinic is believed to be the first at a major U.S. academic medical center dedicated to matching patients with appropriate stem cell clinical trials, whether those research interventions are available at the medical center or at other institutions.
The Heart Institute Regenerative Medicine Clinic offers consultative services for patients with heart and vascular disease who may qualify for investigative stem cell therapy. The goal is to provide research options to patients who remain symptomatic on their current management regimen, or for patients with stable heart disease who are concerned about disease progression.
Over the past decade, medical experts have predicted that in the future, stem cell therapies would transform heart disease treatment and save lives, said Shlomo Melmed, MD, dean of the Cedars-Sinai faculty and the Helene A. and Philip E. Hixon Distinguished Chair in Investigative Medicine. At Cedars-Sinai, we have a track record of successfully directing cardiac stem cell studies as well as transferring innovations from the laboratory to the patient bedside.
In 2009, Marbn and his team completed the worlds first procedure in which a patients own heart tissue was used to grow specialized heart stem cells. The specialized cells were then injected back into the patients heart in an effort to repair and re-grow healthy muscle in a heart that had been injured by a heart attack. Results, published in The Lancet in 2012, showed that one year after receiving the stem cell treatment, heart attack patients demonstrated a significant reduction in the size of the scar left on the heart muscle after a heart attack.
Henry has served as principal investigator of multiple large, multicenter trials in acute coronary syndromes, myocardial infarction and angiogenesis, including several ongoing cardiovascular stem cell trials. He also is principal investigator for one of seven NIH Clinical Cardiovascular Stem Cell Centers.
Our goal is to help make stem cells a regular treatment option for heart disease, Henry said. Right now, many patients with advanced heart disease have limited treatment options. Stem cells offer not only hope but a real chance of a game-changing treatment.
As part of each patients assessment in the Heart Regenerative Medicine Clinic, physicians will evaluate patients interested in participating in stem cell clinical trials at Cedars-Sinai and, for patients willing to travel at other medical institutions across the nation. For patients willing to travel to participate in research, Cedars-Sinai physicians will work closely with investigators at other centers to expedite referrals and seamlessly transfer all relevant medical records.
Read more from the original source:
Cedars-Sinai Heart Institute Opens First-of-its-Kind Research Stem Cell Clinic for Cardiac Patients
Posted in Cell Therapy, Stem Cell Therapy
Comments Off on Cedars-Sinai Heart Institute Opens First-of-its-Kind Research Stem Cell Clinic for Cardiac Patients
Nationally Recognized Beverly Hills Orthopedic Surgeon, Dr. Raj, Now Offering Stem Cell Procedures to Help Patients …
Posted: August 13, 2014 at 7:42 am
Beverly Hills, California (PRWEB) August 11, 2014
Nationally recognized Beverly Hills orthopedic surgeon, Dr. Raj, is now offering stem cell procedures to help patients avoid the need for surgery. This may include joint replacement along with tendon or ligament surgery. For more information on stem cell therapy and scheduling at the Beverly Hills Orthopedic Institute, call (310) 247-0466.
As the benefit of stem cells for repair and regeneration of human tissue has evolved, the opportunity to avoid surgery has too. This includes those with cartilage degeneration, tendonitis and ligament injury. Dr. Raj has been a pioneer in bringing stem cell therapies to the forefront, and is now offering the procedures to all patients.
According to Celebrity Fitness Expert Dr. Raj, a nationally recognized Double Board Certified Orthopedic Surgeon at the Beverly Hills Orthopedic Institute, stem cell injections are being used to heal conditions that used to require surgery. Dr. Raj has been featured on The Doctors, SPIKE TV, NBC, CBS, Martha Stewart Living Radio, Beverly Hills Times and has been named Best of LA by KCAL 9 as well we making Americas Top Orthopedics List in 2007, 2009, 2010, and 2011.
Dr. Raj explains that stem cells have started a medical revolution and have altered the way doctors approach treatment. Stem cells help to regenerate the damaged cartilage within a joint and allow patients to take a more conservative route, adds Dr. Raj. Surgery should be a last case scenario after all other options have been exhausted.
For those individuals suffering from joint arthritis of the hip, knee, shoulder or ankle, surgery is an elective decision with nonsurgical options that traditionally did not alter the course of arthritis. They have merely acted as a "band aid" for pain relief, but not effective at long term relief due to healing arthritis.
Stem cell therapy offers the opportunity for relief and increased activity, while staying out of the operating room. The procedures are outpatient and safe, with minimal risks involved.
For more information on the stem cell procedures provided with the top orthopedic doctor in Los Angeles and Beverly Hills, call (310) 247-0466.
Read this article:
Nationally Recognized Beverly Hills Orthopedic Surgeon, Dr. Raj, Now Offering Stem Cell Procedures to Help Patients ...
Posted in Cell Therapy, Stem Cell Therapy
Comments Off on Nationally Recognized Beverly Hills Orthopedic Surgeon, Dr. Raj, Now Offering Stem Cell Procedures to Help Patients …
ARTAS FUE Hair Transplant and Stem Cell Therapy – Video
Posted: August 9, 2014 at 12:44 pm
ARTAS FUE Hair Transplant and Stem Cell Therapy
Dr. William Yates speaks with another happy patient showing great results after a 2000 graft hair transplant utilizing the ARTAS FUE Robotic Hair Transplant ...
By: William Yates
See the original post:
ARTAS FUE Hair Transplant and Stem Cell Therapy - Video
Posted in Cell Therapy, Stem Cell Therapy
Comments Off on ARTAS FUE Hair Transplant and Stem Cell Therapy – Video
Stem cells show promise for stroke in pilot study
Posted: August 9, 2014 at 12:44 pm
A stroke therapy using stem cells extracted from patients' bone marrow has shown promising results in the first trial of its kind in humans.
Five patients received the treatment in a pilot study conducted by doctors at Imperial College Healthcare NHS Trust and scientists at Imperial College London.
The therapy was found to be safe, and all the patients showed improvements in clinical measures of disability.
The findings are published in the journal Stem Cells Translational Medicine. It is the first UK human trial of a stem cell treatment for acute stroke to be published.
The therapy uses a type of cell called CD34+ cells, a set of stem cells in the bone marrow that give rise to blood cells and blood vessel lining cells. Previous research has shown that treatment using these cells can significantly improve recovery from stroke in animals. Rather than developing into brain cells themselves, the cells are thought to release chemicals that trigger the growth of new brain tissue and new blood vessels in the area damaged by stroke.
The patients were treated within seven days of a severe stroke, in contrast to several other stem cell trials, most of which have treated patients after six months or later. The Imperial researchers believe early treatment may improve the chances of a better recovery.
A bone marrow sample was taken from each patient. The CD34+ cells were isolated from the sample and then infused into an artery that supplies the brain. No previous trial has selectively used CD34+ cells, so early after the stroke, until now.
Although the trial was mainly designed to assess the safety and tolerability of the treatment, the patients all showed improvements in their condition in clinical tests over a six-month follow-up period.
Four out of five patients had the most severe type of stroke: only four per cent of people who experience this kind of stroke are expected to be alive and independent six months later. In the trial, all four of these patients were alive and three were independent after six months.
Dr Soma Banerjee, a lead author and Consultant in Stroke Medicine at Imperial College Healthcare NHS Trust, said: "This study showed that the treatment appears to be safe and that it's feasible to treat patients early when they might be more likely to benefit. The improvements we saw in these patients are very encouraging, but it's too early to draw definitive conclusions about the effectiveness of the therapy. We need to do more tests to work out the best dose and timescale for treatment before starting larger trials."
Follow this link:
Stem cells show promise for stroke in pilot study
Posted in Cell Therapy, Stem Cell Therapy
Comments Off on Stem cells show promise for stroke in pilot study
Cell Separation Technologies Market Expected to Reach USD 3.3 Billion Globally in 2019: Transparency Market Research
Posted: August 9, 2014 at 12:44 pm
ALBANY, New York, August 8, 2014 /PRNewswire/ --
According to a new market report published by Transparency Market Research "Cell Separation Technologies Market (Technology: Gradient Centrifugation, MACS and FACS; Application: Stem Cell Research, Immunology, Neuroscience and Cancer Research) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019", the global cell separation technologies market was valued at USD 1.7 billion in 2012 and is expected to grow at a CAGR of 9.7% from 2013 to 2019, to reach an estimated value of USD 3.3 billion in 2019.
Browse the full Cell Separation TechnologiesMarket Report at http://www.transparencymarketresearch.com/cell-separation-technologies.html
Cells play an important role in the field of microbiology, biotechnology and bioscience which have wide application in pharmaceuticals and healthcare industries. Taking into consideration the increasing demand for cell therapies to treat chronic diseases, research activities targeting cellular therapies have increased tremendously in the last decade. Growth in cell therapy oriented research has escalated demand for cell separation technologies worldwide.
Out of the various types of technologies available in the market, magnetic activated cell sorting (MACS) technology was the major technology segment in 2012, with market share of more than 42.5% in the global cell separation technologies market. Further, fluorescence activated cell sorting (FACS) technology is estimated to capture the market share of rest of the technology segments during the forecast period owing to increased adoption of fluorescence activated cell sorting technology into cell purity sensitive research areas. It is estimated that the global FACS market will reach USD 1,078.5 billion in 2019 growing at a CAGR of 13.9% from 2013 to 2019.
Stem cell research was the major application segment by revenue in the cell separation technologies market in the year 2012. Rising demand for cell therapy and predictable potential of stem cells in the chronic disease treatment have raised the stem cell research activities globally and thereby has resulted in swift growth of the overall cell separation technologies market.
Related & Recently Published Reports by Transparency Market Research
Geographically, North America was the market leader in the global cell separation technologies market in 2012 mainly owing to availability of research funds, highly developed research infrastructure and higher rates of adoption of newer technologies in the practice. Further, growth of the North American cell separation technologies market is driven by factors such as technological advancement, higher healthcare spending and availability of supportive economy to conduct research. In addition, Asia-Pacific is estimated to be a potential market due to rapidly developing healthcare infrastructure on the basis of rapidly increasing medical tourism industry in the Asian countries, mainly in India and Malaysia, increased government support for biotech research and development and large pool of patients suffering from chronic diseases. Some of the key participants operating in this market include BD Bioscience, EMD Millipore, Mitenyi Biotec GmbH, and STEMCELL Technologies and Life Technologies (Thermo Fisher Scientific, Inc.).
The global cell separation technologies market is segmented as follows:
Cell Separation Technologies Market, by Technology
Originally posted here:
Cell Separation Technologies Market Expected to Reach USD 3.3 Billion Globally in 2019: Transparency Market Research
Posted in Cell Therapy
Comments Off on Cell Separation Technologies Market Expected to Reach USD 3.3 Billion Globally in 2019: Transparency Market Research
Due to a radical new approach by stem cell bank BioEden future generations could be guaranteed a stem cell match
Posted: August 9, 2014 at 12:44 pm
(PRWEB UK) 9 August 2014
Stem cell therapy and treatments continue to move on in finding cures for diseases that in the past were thought to be incurable. The success of stem cell treatment and therapy relies to a great extent on the ability for the patient to have a stem cell match. Although stem cell banking has been available for a number of years, the cost for many has been a barrier.
Specialist stem cell bank BioEden who operate in 21 countries have come up with a solution that brings this potentially life saving opportunity within an affordable range for the majority.
Their aim is to make stem cell therapy an affordable reality and hope that their new approach which includes a low monthly membership option will do just that.
As more and more people bank their children's stem cells for their future use, the problem of finding a stem cell match could become a thing of the past.
Continue reading here:
Due to a radical new approach by stem cell bank BioEden future generations could be guaranteed a stem cell match
Posted in Cell Therapy, Stem Cell Therapy
Comments Off on Due to a radical new approach by stem cell bank BioEden future generations could be guaranteed a stem cell match
Stem cell stroke therapy shows promise after first human trial
Posted: August 9, 2014 at 12:44 pm
A pilot study undertaken by researchers from Imperial College Healthcare NHS Trust and Imperial College London has shown promise in rapid treatment of serious strokes. The study, the first of its kind published in the UK, treated patients using stem cells from bone marrow.
Imagine a perfectly ordinary beginning to your day, say burned toast, no matching pair of socks and the usual damp commute to work. Except at some point through the usual minutiae you suffer a massive stroke. If you dont die outright, you may soon afterwards. Even supposing you survive those first days or weeks, the chance of your life resuming its comforting tedium is impossibly remote. You may need assistance for the rest of your shortened life.
According to the Stroke Association, about 152,000 people suffer a stroke in the UK alone each year. However, the five patients treated in the recent Imperial College pilot study all showed improvements. According to doctors, four of those had suffered the most severe kind of stroke, which leaves only four percent of people alive or able to live independently six months after the event. All four of the patients were alive after six months.
A particular set of CD34+ stem cells was used, as they help with the production of blood cells and blood vessels lining cells. These same cells have been found to improve the effects of stroke in animals, and they assist in brain tissue and blood growth in the affected areas of the brain. The CD34+ cells were isolated from samples taken from patients bone marrow and then infused into the affected area via an artery that leads to the brain, using keyhole surgery.
The innovative stem cell treatment differs from others in one important way: patients are treated within seven days of their stroke, rather than six months hence. The stroke sufferers all recorded improvements in terms of clinical measures of disability, despite four of the five having suffered the most severe kind of stroke.
It's still early days for the research, and much more will need to be done to expand clinical trials, but eventually it is hoped that a drug may be developed that can be administered to stroke sufferers as soon as they are admitted to hospital. This could ameliorate longer term effects and allow for speedier recovery and a faster entry into therapy.
A paper detailing the research was published in journal Stem Cells Translational Medicine.
Source: Imperial College London
Here is the original post:
Stem cell stroke therapy shows promise after first human trial
Posted in Cell Therapy
Comments Off on Stem cell stroke therapy shows promise after first human trial
PHYTOSCIENCE PHILIPPINES DOUBLE SKIN CELL THERAPY REVIEW – Video
Posted: August 8, 2014 at 4:48 am
PHYTOSCIENCE PHILIPPINES DOUBLE SKIN CELL THERAPY REVIEW
PHYTOSCIENCE PHILIPPINES DOUBLE SKIN CELL THERAPY REVIEW A RARE OPPORTUNITY TO ALL FILIPINOS BE A PART OF THE PHYTOSCIENCE PIONEERING TEAM 2013 Best Selling ...
By: phytoscience double stem cell philippines
Read the original here:
PHYTOSCIENCE PHILIPPINES DOUBLE SKIN CELL THERAPY REVIEW - Video
Posted in Cell Therapy
Comments Off on PHYTOSCIENCE PHILIPPINES DOUBLE SKIN CELL THERAPY REVIEW – Video
Edu Manzano considering stem-cell treatment for his back problem
Posted: August 8, 2014 at 4:46 am
Kasalukuyan daw uma-attend si Edu Manzano ng mga seminar tungkol sa stem cell therapy.
Nagbabalak kasi ang TV host na sumailalim sa nasabing treatment.
Subalit hindi 'tulad ng iba, kung saan pag-iwas sa mabilisang pagtanda ang dahilan, gagawin daw ito ni Edu para sa kanyang problema sa likod.
Sa panayam ng PEP.ph (Philippine Entertainment Portal) at ibang reporters kanina, August 7, sinabi ni Edu, In my case, its for my back because of the accidents that Ive suffered during mga stunts in my 30 years in the movie.
Nagbigay rin siya ng ilang patunay na hindi lamang para sa vanity ang stem-cell treatment.
Aniya, Actually, people are talking about stem cells now.
But there are still misconceptions about stem cells.
You know, its not always about youth.
"Ive seen a friend who had a heart attack.
I have a friend who has failing vision, declared legally blind, in-inject talaga sa mata, nakakakita na siya, nagmamaneho na siya.
See the original post here:
Edu Manzano considering stem-cell treatment for his back problem
Posted in Cell Therapy
Comments Off on Edu Manzano considering stem-cell treatment for his back problem
BioEden fights the financial cost of stem cell banking by bringing their specialist service to the people for just 5 …
Posted: August 7, 2014 at 8:44 am
(PRWEB UK) 7 August 2014
BioEden the specialist tooth stem cell bank stands by its pledge to make personalised stem cell therapy an affordable reality by launching Access Membership at just 5 per month.
With stem cell therapy holding the promise of longer and better lives in the future, the cost and the ease of finding a stem cell match has been an issue, given that the cost of private stem cell banking requires an initial cash outlay of up to 4000.
Not any more.
BioEden the leading specialist tooth stem cell bank, has added Access Membership to parents finding themselves financially unable to bank their child's cells for future use. "It doesnt sit well with us that a parent could be unable to access what could be a life saving service for their child, for financial reasons," said Group CEO Mr Tony Veverka.
Parents can access the stem cell banking service for just 5 per month, and can become a member of the plan as soon as the baby is born. To date the option for stem cell banking at birth has been umbilical cord blood banking, an invasive process which provides haemopoetic stem cell banking at a cost.
Now parents have the option to choose tooth stem cell banking or to add this to cord blood banking at a very low monthly cost.
Tooth stem cells have considerable advantages over cord blood cells;
And now, thanks to BioEden, cost doesnt have to be a barrier.
So how can 5 a month give access to such a specialist service?
Read the original:
BioEden fights the financial cost of stem cell banking by bringing their specialist service to the people for just 5 ...
Posted in Cell Therapy
Comments Off on BioEden fights the financial cost of stem cell banking by bringing their specialist service to the people for just 5 …